Viridian Therapeutics Inc (VRDN)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 12-2023 | 12-2022 | 12-2021 | 12-2020 | 12-2019 | |
| Sales | 314 | 1,772 | 2,963 | 1,050 | 4,461 |
| Gross Profit | 314 | 1,772 | 2,963 | 1,050 | 4,461 |
| Operating Expenses | 254,764 | 136,076 | 82,691 | 111,430 | 46,440 |
| Operating Income | -254,450 | -134,304 | -79,728 | -110,380 | -41,979 |
| Interest Expense | 1,847 | 486 | 3 | 508 | 835 |
| Other Income | 18,563 | 4,916 | 318 | 173 | 941 |
| Pre-tax Income | -237,734 | -129,874 | -79,413 | -110,715 | -41,873 |
| Net Income Continuous | -237,734 | -129,874 | -79,413 | -110,715 | -41,873 |
| Net Income | $-237,734 | $-129,874 | $-79,413 | $-110,715 | $-41,873 |
| EPS Basic Total Ops | -5.31 | -4.05 | -6.66 | -31.13 | -20.04 |
| EPS Basic Continuous Ops | -5.31 | -4.05 | -6.66 | -31.13 | -20.04 |
| EPS Diluted Total Ops | -5.31 | -4.05 | -6.66 | -31.13 | -20.04 |
| EPS Diluted Continuous Ops | -5.31 | -4.05 | -6.66 | -31.13 | -20.04 |
| EPS Diluted Before Non-Recurring Items | -5.31 | -4.05 | -6.68 | -11.49 | -20.09 |
| EBITDA(a) | $-265,418 | $-134,259 | $-78,643 | $-109,804 | $-42,123 |